They have written clinical data that demonstrates both the clinical and economic benefits of thier product.
They have engaged activity with an IR firm so this should begin to attract more investors and share price should spike soon.
They have increased activity with their sales and marketing by increasing the sales force.
It looks like they realize the value in increasing shareholder equity and will begin to change thier attitude to attract larger investors. Then funding for increased operations will be forth coming.
Any posts are just an opinion and should not be taken as investment advice. Always do your own DD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.